throbber
Handbook of
`Pha rmaceutica I Exc i Tents
`p
`
`FOURTH EDITION
`
`Edited by
`
`Raymond C Rowe
`BPharm, PhD, DSc, fRPharmS, CChem, FRSC, CPhys, MlnstP
`
`Senior Principal Scienfist
`
`AshaZeneca
`
`Macclesfield, UK
`
`Paul J Sheskey
`BSc, RPh
`
`Technical Service Leader
`
`Water Soluble Polymers RB~D
`
`The Dow Chemital Company
`
`Midland
`
`MI, USA
`
`Paul J Weller
`BSc, MSc, CChem, MRSC
`
`Publisher —Science and Practice
`Royal Pharmaceutical Society of Great Britain
`
`London, UK
`
`h
`London ~ Chicago Pharmaceutical Press
`
`0
`
`American
`Pharmaceutical
`Association
`
`Page 1
`
`SHIRE EX. 2064
`KVK v. SHIRE
`IPR2018-00290
`
`

`

`Published by the Pharmaceutical Press
`Publications division of the Royal Pharmaceutical Society of Great Britain
`
`1 Lambeth High Street, London SE1 7JN, UK
`100 South Atkinson Road, Suite 206, Grayslake, IL 60030-7820, USA
`
`and the American Pharmaceufical Assaiation
`2215 Constitution Avenue NW, Washington, DC 20037-2985, USA
`
`C Pharmaceutical Press and American Pharmaceutical Association 2003
`
`(PP/ is a trade mark of Pharmaceutical Press
`
`First edition published 1986
`Second edition published 1994
`Third edition published 2000
`Fourth edition published 2003
`
`Text design by Barker Hilsdon, Lyme Regis
`Typeset by Bibliocraft Ltd, Dundee
`Printed in Great Britain by The Bath Press, Bath
`
`ISBN 0 85369 4?2 9 (iJIC)
`ISBN 1 58212 022 6 (USA)
`
`All rights reserved. No part of this publication may be
`reproduced, stored in a retrieval system, or transmitted in any
`form or by any means, without the prior written permission
`of the copyright holder.
`The publisher makes no representation, express or implied,
`with regard to the accuracy of the information contained in
`this book and cannot accept any legal responsibility or
`liability for any errors or omissions that may be made.
`
`A catalogue record for this book is available from the British Library
`
`Library of Congress Cataloging-in-Publication Data
`Handbook of pharmaceutical excipients.-4th ed. /edited by Rar'mond C.
`Rowe, Paul J. Sheskey, Paul J. DG'eller.
`p. ; cm.
`Includes bibliographical references and index.
`ISBN 1-58212-022-6 (alk. paper) —ISBN 0-85369-472-9 (alk. paper)
`1. Excipients—Handbooks, manuals, etc.
`[DNLM: 1. Excipients—Handbooks. QV 735 H236 2003] I. Rowe, Raymond
`C. II. Sheskey, Paul J. III. a'eller, Paul J.
`
`RS201.E87H36 2003
`615'.19~c21
`
`2003002641
`
`Page 2
`
`

`

`Preface
`
`PHARMACEUTICAL DOSAGE FORMS contain both pharma-
`cologically active compounds and excipients added to aid the
`formulation and manufacture of the subsequent dosage form
`for administration to parients. Indeed, the properties of the final
`dosage form (i.e. its bioavailability and stability) are, for the
`most part, highly dependent on the excipients chosen, their
`concentrarion and interaction with both the active compound
`and each other. No longer can excipients be regarded simply as
`inert or inactive ingredients, and a detailed knowledge not only
`of the physical and chemical properties but also of the safety,
`handling and regulatory status of these materials is essential for
`formulators throughout the world. In addition, the growth of
`novel forms of delivery has resulted in an increase in the number
`of the excipients being used and suppliers of excipients have
`developed novel excipient mixtures and new physical Eorms to
`improve their properties. The Handbook o f Pharmaceutical
`Excipients has been conceived as a systematic, comprehensive
`resource of information on all of these topics.
`The first edition of the Handbook was published in 1986
`and contained 145 monographs. This was followed by the
`second edition in 1994 containing 203 monographs and the
`third edition in 2000 containing 210 monographs. Since the
`release of the third edition two CD-ROM editions have also
`been released: Pharmaceutical Excipients 2000 included the
`same material as the third edirion, and Pharmaceutical
`Excipients 2001, which included 20 new monographs.
`This new printed edition with its companion CD-ROM
`contains 250 monographs authored by experts in pharmaceu-
`tical formulation or excipient manufacture from around the
`world. All the monographs have been reviewed and revised in
`the light of current knowledge. There has been a greater
`emphasis on including published data from primary sources
`although some data from laboratory projects included in
`previous editions have been retained where relevant. Varia-
`tions in test methodology can have significant effects on the
`data generated (especially in the case of the compactability of
`an excipient), and thus cause confusion. As a consequence, the
`editors have been more selective in including data relating to the
`physical properties of an excipient. However, comparative data
`that show differences between either source or batch of a
`specific excipient 'have been retained as this was considered
`relevant to the behavior of a material in practice. The Suppliers
`Directory (Appendix I) has also been completely updated with
`many more internarional suppliers included.
`In a systemaric and uniform manner, the Handbook o f
`Pharmacez~tical Excipients collects essenrial data on the physi-
`cal properties of excipients such as: boiling point, bulk and tap
`density, compression characteristics, hygroscopicity, flow-
`ability, melting point, moisture content, moisture-absorption
`isotherms, particle size distribution, rheology, specific surface
`area, and solubility. Scanning electron microphotographs
`(SEMs) are also included for many of the excipients. The
`H. andbook contains information from various internarional
`sources and personal observation and comments from
`monograph authors, steering committee members, and the
`editors.
`
`All of the monographs in the Handbook aze thoroughly
`cross-referenced and indexed so that excipients may be idenri-
`fied by either a chemical, a nonproprietary, or a trade name.
`Most monographs list related substances to help the formulator
`to develop a list of possible materials for use in a new dosage
`form or product. Related substances aze not directly substitu
`table for each other but, in general, they aze excipients that have
`been used for similar purposes in various dosage forms.
`The Handbook of Phar~naceutica~ Excipients is a compre-
`hensive, uniform guide to the uses, properties, and safety of
`pharmaceutical excipients, and is an essential reference source
`for those involved in the development, production, control, or
`regulation of pharmaceutical preparations. Since many phar-
`maceutical excipients are also used in other applications, the
`Handbook o f Pharmaceutical Excipients will also be of value to
`persons with an interest in the formularion or production of
`confectionery, cosmetics, and food products.
`
`Arrangement
`
`The information consists of monographs that are divided into
`22 sections to enable the reader to find the information of
`interest easily. Although it was originally intended that each
`monograph contain only information about a single excipient, it
`rapidly became clear that some substances or groups of sub-
`stances should be discussed together. This gave rise to such
`monographs as `Coloring Agents' and `Hydrocarbons'. In addi-
`tion, some materials have more than one monograph depending
`on the physical characteristics of the material, e.g. Starch versus
`Pregelatinized Starch. Regardless of the complexity of the
`monograph they are all divided into 22 sections as follows:
`
`1 Nonproprietary Names
`2 Synonyms
`3 Chemical Name and CAS Registry Number
`4 Empirical Formula and Molecular Weight
`5 Structural Formula
`6 Functional Category
`7 Applications in Pharmaceutical Formulation or Technology
`8 Description
`9 Pharmacopeial Specifications
`10 Typical Properties
`11 Stability and Storage Conditions
`12 IncomparibIliues
`13 Method of Manufacture
`14 Safety
`15 Handling Precautions
`16 Regulatory Status
`17 Related Substances
`18 Comments
`19 Specific References
`20 General References
`21 Authors
`22 Date of Revision
`
`Descriptions of the sections appear below with information
`from an example monograph if needed.
`
`xVil
`
`Page 3
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket